Cutting Corporate Welfare: on Health Care

Enforce fair drug prices if sponsored by govt research

In the critical area of pharmaceuticals, this research giveaway policy leads to superprofiteering by drug manufacturers, who charge unconscionably high prices for important medicines-costing consumers, and often resulting in the denial of treatment to consumers who are unable to pay high prices.

Where the government hands an annual billion-dollar revenue earner [like exclusive licenses to distribute government-researched medicines] to a private company for a pittance, is it too much to ask the relevant federal agency to enforce reasonable pricing requirements? This has resulted in a failure to avert preventable cancer deaths. Shame clearly will not work as a disciplinary force to limit corporate welfare abuses.